How To Write Covered Calls - An Ongoing Real Case Study! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : How To Write Covered Calls - An Ongoing Real Case Study!

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: rkf who wrote (7190)	3/29/1998 12:06:00 PM
From: Herm	Read Replies (1) of 14162

Thanks RKF! Well, I would venture to say as time passes we will hear more about the particular and general side effects of the oral ED pill. ALL drugs have side effects. It would be safe to say that no one drug for ED will capture the exclusive majority since bio-technology will continue to find new ways to treat the problem. Market share yes, but not an outright exclusive even if it has be proven to be effective. In any case, a market cut for VVUS would still result in a profitable share of the big pie. The P/E needs to return back to a reasonable level. When I needed allegy medications many years ago (which I continue to take to this day) my doctor prescribed a few drugs for me to sample to determine which one worked best for me. Such would be the case for ED patients through their doctors. That means at least initial sales for VVUS on PFE's world wide marketing muscle. I would rather have a small and significant percentage of a very large market than a large percentage of a small market share. Let's get that FDA approval soon and crank up those 6 production lines and rack up some the profits for the remaining 1998 fiscal year for VVUS.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next